336 related articles for article (PubMed ID: 25136857)
21. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
Thorelli E; Kaufman RJ; Dahlbäck B
J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
[TBL] [Abstract][Full Text] [Related]
22. Strenuous exercise promotes shear-induced thrombin generation by increasing the shedding of procoagulant microparticles from platelets.
Chen YW; Chen JK; Wang JS
Thromb Haemost; 2010 Aug; 104(2):293-301. PubMed ID: 20589321
[TBL] [Abstract][Full Text] [Related]
23. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
[TBL] [Abstract][Full Text] [Related]
24. Emicizumab-mediated haemostatic function in patients with haemophilia A is down-regulated by activated protein C through inactivation of activated factor V.
Yada K; Nogami K; Shinozawa K; Kitazawa T; Hattori K; Amano K; Fukutake K; Shima M
Br J Haematol; 2018 Oct; 183(2):257-266. PubMed ID: 30125997
[TBL] [Abstract][Full Text] [Related]
25. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn ) associated with activated protein C resistance.
Pezeshkpoor B; Castoldi E; Mahler A; Hanel D; Müller J; Hamedani NS; Biswas A; Oldenburg J; Pavlova A
J Thromb Haemost; 2016 Jul; 14(7):1353-63. PubMed ID: 27090446
[TBL] [Abstract][Full Text] [Related]
26. Plasma protein S residues 37-50 mediate its binding to factor Va and inhibition of blood coagulation.
Heeb MJ; Mesters RM; Fernández JA; Hackeng TM; Nakasone RK; Griffin JH
Thromb Haemost; 2013 Aug; 110(2):275-82. PubMed ID: 23892573
[TBL] [Abstract][Full Text] [Related]
27. The regulation of clotting factors.
Kalafatis M; Egan JO; van 't Veer C; Cawthern KM; Mann KG
Crit Rev Eukaryot Gene Expr; 1997; 7(3):241-80. PubMed ID: 9399073
[TBL] [Abstract][Full Text] [Related]
28. A new regulatory function of activated factor V: inhibition of the activation by tissue factor/factor VII(a) of factor X.
Al Dieri R; Bloemen S; Kelchtermans H; Wagenvoord R; Hemker HC
J Thromb Haemost; 2013 Mar; 11(3):503-11. PubMed ID: 23294934
[TBL] [Abstract][Full Text] [Related]
29. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.
Hackeng TM; van 't Veer C; Meijers JC; Bouma BN
J Biol Chem; 1994 Aug; 269(33):21051-8. PubMed ID: 8063724
[TBL] [Abstract][Full Text] [Related]
30. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
Connor DE; Exner T; Ma DD; Joseph JE
Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
[TBL] [Abstract][Full Text] [Related]
31. 4-Hydroxy-2-nonenal enhances tissue factor activity in human monocytic cells via p38 mitogen-activated protein kinase activation-dependent phosphatidylserine exposure.
Vatsyayan R; Kothari H; Pendurthi UR; Rao LV
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1601-11. PubMed ID: 23640483
[TBL] [Abstract][Full Text] [Related]
32. Thrombotic Role of Blood and Endothelial Cells in Uremia through Phosphatidylserine Exposure and Microparticle Release.
Gao C; Xie R; Yu C; Ma R; Dong W; Meng H; Zhang Y; Si Y; Zhang Z; Novakovic V; Zhang Y; Kou J; Bi Y; Li B; Xie R; Gilbert GE; Zhou J; Shi J
PLoS One; 2015; 10(11):e0142835. PubMed ID: 26580207
[TBL] [Abstract][Full Text] [Related]
33. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.
Yegneswaran S; Nguyen PM; Gale AJ; Griffin JH
Thromb Haemost; 2009 Jan; 101(1):55-61. PubMed ID: 19132189
[TBL] [Abstract][Full Text] [Related]
34. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C.
Taylor FB; Hoogendoorn H; Chang AC; Peer G; Nesheim ME; Catlett R; Stump DC; Giles AR
Blood; 1992 Apr; 79(7):1720-8. PubMed ID: 1558968
[TBL] [Abstract][Full Text] [Related]
36. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.
van Doorn P; Rosing J; Duckers C; Hackeng TM; Simioni P; Castoldi E
Thromb Haemost; 2018 Jul; 118(7):1194-1202. PubMed ID: 29864781
[TBL] [Abstract][Full Text] [Related]
37. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
38. Regulation of prothrombinase activity by protein S.
van 't Veer C; Butenas S; Golden NJ; Mann KG
Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanism of the dysfunction of protein S(Tokushima) (Lys155-->Glu) for the regulation of the blood coagulation system.
Hayashi T; Nishioka J; Suzuki K
Biochim Biophys Acta; 1995 Dec; 1272(3):159-67. PubMed ID: 8541347
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of thrombin formation by active site mutated (S360A) activated protein C.
Nicolaes GA; Bock PE; Segers K; Wildhagen KC; Dahlbäck B; Rosing J
J Biol Chem; 2010 Jul; 285(30):22890-900. PubMed ID: 20484050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
